Stryker to Acquire Inari Medical, Boosts Vascular Device Portfolio
Stryker's acquisition of Inari Medical enhances its vascular medical device offerings, strengthening its position in the healthcare market.
Topic
Stryker
A collection of 11 issues
Stryker to Acquire Inari Medical for $80/Share
Inari Medical's stock soared following news of its acquisition by Stryker for $80 per share. Discover the impact on the medical device market.
Stryker Shares Dip 1.7% After Acquisition News
Stryker's stock fell 1.7% in premarket trading post-acquisition announcement. Discover the impact of this strategic move on market performance.
Stryker Expands Vascular Device Portfolio with Acquisition
Stryker's acquisition broadens its medical device offerings, enhancing solutions for vascular health. Learn more about this strategic expansion.
Stryker Acquires Inari Medical for $4.9 Billion
Stryker announces acquisition of Inari Medical in an all-cash deal at $80 per share, valuing the company at approximately $4.9 billion.
Stryker Acquires Inari Medical: A Strategic Healthcare Move
Explore Stryker's strategic acquisition of Inari Medical, a significant expansion in the healthcare sector. Learn its impact on market dynamics.
Stryker to Address Acquisition's Financial Impact in Earnings Call
Stryker is set to reveal the financial implications of its recent acquisition during the upcoming earnings call on January 28. Stay updated on Stryker's financial strategies.
Inari Medical Shares Surge 30% on Stryker's $4.9B Acquisition Bid
Inari Medical's stock skyrockets 30% following Stryker's $4.9 billion acquisition proposal. Discover the impact on the medical device industry.
Stryker Acquires Inari Medical for $4.9B; Shares Dip
Stryker's shares edge down after announcing the $4.9 billion acquisition of Inari Medical. Explore how this strategic move could impact market dynamics.
Inari Medical Stock Jumps 30% on Stryker Acquisition Offer
Inari Medical shares surged 30% after Stryker announced a $4.9 billion acquisition bid. Discover the implications for the medical tech market.